Technical guide

Liposomal and water-soluble forms: what is the difference?

Water solubility and liposomal structure describe different properties. The first concerns behaviour in water under defined conditions; the second describes a carrier system. Assessing them separately helps avoid misleading technology comparisons and incorrect calculations during product development.

What does solubility describe?

Solubility is related to the composition of a saturated solution in a specified solvent under defined conditions. A reported value should therefore be accompanied by temperature, pH, solvent, units and test method. A uniform appearance after mixing does not replace a quantitative solubility measurement.

Even when a supplier describes an ingredient as water-soluble, that property should be evaluated at the intended concentration and in the actual finished-product environment.

Source: IUPAC Gold Book — Solubility; IUPAC Gold Book — Colloidal dispersion

What does liposomal structure describe?

The term liposomal refers to a phospholipid-based carrier structure. Suitable characterisation evidence is needed to establish whether a formulation that mixes uniformly with water has that structure. Imaging methods such as TEM and particle-size measurements contribute different information.

A proprietary platform name alone is not enough to classify every ingredient using that platform as liposomal. Check how the manufacturer defines the particular product and the evidence supplied for it.

Source: FDA (2018) — Liposome Drug Products; structure and composition; NCI — Particle characterisation methods

Compare quotations on the same basis

PropertyInformation to clarify
Physical formPowder or liquid; complete active and carrier composition
Water solubilityMethod, conditions, quantity tested and result
Liposomal structureCharacterisation method and identity of the tested sample
Active contentWhether the percentage refers to the active, its compound or a mixture
BioavailabilityTested formulation, active dose and comparator

The same active name does not mean the same material calculation

As an illustrative calculation, 500 mg of a formulation containing 20% active would provide a nominal 100 mg of that active. This is not a product recommendation or use level. It demonstrates why formulation weight and active weight should be recorded separately.

A comparison of price per kilogram should consider active content expressed on the same basis, the target serving, carrier contribution and manufacturing usability. A water-compatible appearance or a higher assay percentage alone does not establish the best finished-product option.

Selecting a form with Biontera

Share the intended dosage format, active amount and manufacturing conditions so we can assess liposomal and water-soluble options using their respective technical files. Sample work provides a practical comparison of appearance, dissolution behaviour, sensory properties and compatibility with other ingredients.

Common questions

Is every water-soluble product liposomal?

No. Water solubility does not establish the presence of a liposomal carrier. Structural characteristics need separate assessment.

Does a liposomal ingredient have to be transparent?

No. Appearance depends on composition and particle characteristics. Clarity or turbidity alone does not establish structure or quality.

Which form is better?

The choice depends on the target product. Technical documentation, active amount, process compatibility and sample results should be assessed together.

Explore the portfolio

From understanding to selection.

Let’s assess your next formulation.

Share your dosage form, intended amount per serving and estimated annual requirement. We can plan ingredient selection, technical documentation and sample evaluation together.

Discuss documents and samples